E-COMPARED Executive Committee meeting
Date and time: 5/6/2014, 12:00-13:00 CET
Venue: telephone conference
Agenda
12:00 – 12:05
1. Welcome & Agenda
12:05 – 12:20
2. WP1, WP3, WP4, WP5 and WP6 (5 min each):
•
Update progress, actions and planning
•
Main (scientific) issues that needs to be discussed
12:20 – 12:30
3. WP2 Trial protocol - finalisation
• Key issues to discuss
• Ethical approval and Next steps to finalise
12:30 – 12:40
4. Technical pilots
• Aim, planning and next steps
12:40 – 12:45
Chair: prof. dr. Heleen Riper
12:45 – 12:50
5. Board Meeting Valencia 20 -21 October 2014
12:50 – 13:00
6. AOB & Closure
• Next ExC meeting
Participants
Heleen Riper (VUA, Chair), Gerhard Andersson (LiU, WP1), Pim Cuijpers (VUA, WP2), Annet Kleiboer (VUA,
WP2), Karine Chevreul (Inserm, WP3), Burkhardt Funk (ULG, WP4), Rosa Baños (UVEG, WP5), Tobias Krieger
(UBern, WP6), Christiaan Vis (VUA, WP7), Eirini Karyotaki (VUA, minutes).
Absent: Jan Smit (GGZ InGeest, announced); Cristina Botella (JAUME, announced); Thomas Berger (announced)
Action points
What
Planning for deciding on trial protocol.
Testing template for evaluation of Technical
pilots
Process changes in Dissemination Plan
Who
Annet Kleiboer (VUA)
Jeroen Ruwaard (VUA) / Christiaan Vis (VUA)
When
Mid August
Mid August
Thomas Berger (UBern) / Tobias Krieger
(UBern)
Heleen Riper (VUA) / Christiaan Vis (VUA)
End of June
Request for information on delivery of
dissemination plan to Commission
Interim Internal reporting tool (development) Christiaan Vis (VUA)
Next Executive Committee Meeting: Thursday 4th of September at 12 to 13h.
End of June
July
Minutes
1. Welcome and Agenda
1


Christiaan Vis opens the meeting at 12h.
Main goal of the meeting: progress monitoring, discussion of the generic protocol and the technical
pilots
2. WP1, 3, 4 and 5
Status update and important issues
WP1
Progress is good, on track and in time:
 Excel file report, work in progress.
 Stakeholder survey, 200 responses (few more from Netherlands).
 On track with the deadline (the report will be ready in December).
WP3
Progress is good:
 A WP meeting took place on 13th of May at which the pros and cons of Markov modelling and possible
alternatives were discussed. As a result, a literature study is started to enable for an informed decision
on which model is best suitable to the data we expect. It might be possible to develop two models.
Decision will take place in September.
WP4




3 PhD Aare already working (1 PhD will be hired in the beginning of July)
Extension of the existing model (ICT4D): i. extent it to other content (e.g. emotional regulation), ii. Use
the existing model by applying new statistical methods
Use data from a study in Lunenburg (a big European project that will be presented at the ISRII
conference 2014)
We need to see how the EMA component will be included in different studies
WP5


Template with the data
New Info from WP1 and WP2, will be used to update the template (however, changes are expected)
WP6


Dissemination Draft plan; all are asked to provide their input.
The website is running, including the secured part.
3. Trial protocol

Updating the protocol with suggestions from the consortium. The most important are:
o We need to think more about the trial design (how we should design it further), the power
needed both for the individual and collective analyses etc.
o Secondary care trials differ in several ways from primary care trials
o The Solomon 4 design (EMA) is complicated, we need to check what the consequences will
be for each country (e.g. power)
2
o

EMA in both experimental and control group: differences between secondary and primary
care? If EMA in both groups is not feasible, we will consider the possibility of gathering EMA
data only from 1 condition, or for both conditions for those trial sites who can do so.
We decided on the following procedure on decision-making in these issues: i. A small team of NL
experts is established and issues will be discussed (Cuijpers, Smit, Kleiboer & Riper). Ii. External
statistical experts will be consulted to address the issues mentioned above, iii. Results will be
discussed with the Consortium trial partners. Iv. A final decision on the design will be then taken. A
planning with deadline (Kleiboer) will be drafted and presented at the end of August.
4. Pilots





We need to secure the intervention delivery
To this end, all trial sites should perform the technical pilots at the last quarter of this year and identify
the difficulties. For most of the platforms and interventions, this can be a brief test.
In October - November 2014 we need to have the information from the pilot studies (before the
beginning of the recruitment in January 2015)
To prepare the technical pilots, a dedicated testing template for evaluation will be developed by Jeroen
Ruwaard (VUA) and Christiaan Vis (VUA) and send out to all trial sites at the end of August.
Sweden has already conducted a clinical trial with their platform. They may use the data from this trial
for the purpose of the technical evaluation. We may also use their clinical data as part of our
deliverable.
4. Dissemination
Dissemination Plan:
 Draft of dissemination plan with key messages to different stakeholder groups, dissemination tools,
website and frequent of dissemination.
 Proposal accepted: all partners provide a short description and a list of activities that they are planning
to perform in their region in order to promote E-COMPARED project.
 Plan will be ready at the end of June and it will be updated every 6 months (the deliverable is at the end
of the project). VUA will contact the representatives of the Commission to check what do they want in
respect to dissemination plan and its delivery.
Sharing stakeholder information with MasterMind project:
 The VUA and GGZ inGeest (and Erlangen, Matthias Berking as well) are involved in a large-scale
implementation and up-scaling project financed by the EC, called MasterMind. For their stakeholder
analysis, the MasterMind project management team approached us to share E-COMPARED’s
information on stakeholders. The question now is if this can be accepted keeping in mind e.g. possible
privacy issues. It has been decided that sharing the information with MasterMind is beneficial to both
the EC and the E-COMPARED and MasterMind stakeholders as there is a shared goal.
5. Any other Businesses
3




ISRII Conference, 23-25/10 in Valencia
20-22/10 E-Compared Meeting in Valencia, representatives of EU/ FP7 will participate as well as experts
from the E-COMPARED External Scientific Committee,
At the end of August the partners will receive the draft agenda for this meeting.
An internal reporting tool for the expenses will be developed by Christiaan Vis (VUA), and sent out
during the summer to collect the information for the first internal reporting period covering the first 6
months.
6. Closure



Next conference call meeting is scheduled for Thursday 4th of September at 12 to 13h.
If urgent issues arise, an ad-hoc meeting can be arranged for.
Heleen closes the meeting at 13:00 o’clock.
4